Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta and Mavrilimumab in Relapsed or Refractory...
SANTA MONICA, Calif., & HAMILTON, Bermuda--(BUSINESS WIRE)--Dec 11, 2019--
SANTA MONICA, Calif., & HAMILTON, Bermuda--(BUSINESS WIRE)--Dec 11, 2019--